Cargando…

A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism

BACKGROUND: Activated protein C resistance (APCR) due to factor V Leiden (FVL) mutation (R506Q) is a major risk factor in patients with venous thromboembolism (VTE). The present study investigated the clinical manifestations and the risk of venous thromboembolism regarding multiple clinical, laborat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takhviji, Vahideh, Zibara, Kazem, Maleki, Asma, Azizi, Ebrahim, Hommayoun, Sanaz, Tabatabaei, Mohammadreza, Ahmadi, Seyed Esmaeil, Soleymani, Maral, Ghalesardi, Omid Kiani, Farokhian, Mina, Davari, Afshin, Paridar, Pouria, Kalantari, Anahita, Khosravi, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527672/ https://www.ncbi.nlm.nih.gov/pubmed/34666770 http://dx.doi.org/10.1186/s12959-021-00328-0

Ejemplares similares

Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients
por: Paridar, Mostafa, et al.
Publicado: (2021)

Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19
por: Issa, Hawraa, et al.
Publicado: (2021)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015)

5558131 GENETICS OF IRANIAN ALPHA THALASSEMIA PATIENTS; COMPREHENSIVE ORIGINAL STUDY
por: Khosravi, A., et al.
Publicado: (2023)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
por: Reddington, Hayley, et al.
Publicado: (2020)

Effects of factor v Leiden polymorphism on the pathogenesis and outcomes of preeclampsia
por: Ababio, G. K., et al.
Publicado: (2019)

Wolfgang Pauli in Leiden
por: Unknown
Publicado: (1953)

Is there a relationship between factor V Leiden and type 2 diabetes?
por: Lodigiani, Corrado, et al.
Publicado: (2009)

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Factor V Leiden mutation: An added risk in single ventricle palliation
por: Saileela, R, et al.
Publicado: (2012)

Multiple Brain Abscesses in an Immunocompetent Patient With Factor V Leiden Mutation
por: Zafar, Saeed Zubair, et al.
Publicado: (2016)

Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
por: Yıldız, Eray, et al.
Publicado: (2020)

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism
por: el marraki, Zakaria, et al.
Publicado: (2022)

Ophthalmic Vein Thrombosis Associated with Factor V Leiden and MTHFR Mutations
por: Teodoru, Cosmin Adrian, et al.
Publicado: (2023)

Prevalence of Intestinal Protozoa Infections and Associated Risk Factors among Schoolchildren in Sanandaj City, Iran
por: BAHMANI, Pegah, et al.
Publicado: (2017)

Deficiencies of proteins C, S and Antithrombin and factor V Leiden and the risk of ischemic strokes
por: Soare, AM, et al.
Publicado: (2010)

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
por: Katzav, Aviva, et al.
Publicado: (2013)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
por: Reddy, R R N, et al.
Publicado: (2019)

Apples in Amsterdam and oranges in Leiden
por: Koster, R. W.
Publicado: (2014)

Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
por: Kreidy, Raghid
Publicado: (2012)

Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
por: Kheradmand, Ehsan, et al.
Publicado: (2017)

American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing
por: Grody, Wayne W., et al.
Publicado: (2001)

Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis
por: Yusuf, Mohd, et al.
Publicado: (2012)

Epidemiology of Activated Protein C Resistance and Factor V Leiden Mutation in the Mediterranean Region
por: Jadaon, Mehrez M.
Publicado: (2011)

To determine the frequency of Factor V Leiden in cases of Deep Vein Thrombosis and Healthy controls
por: Saeed, Anjum, et al.
Publicado: (2015)

Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation
por: Mohapatra, Sitikant, et al.
Publicado: (2017)

Two successful cases of DIEP flaps for breast reconstruction in patients with Factor V Leiden
por: Zavlin, Dmitry, et al.
Publicado: (2018)

Isolated pulmonary embolism in a patient with progestin intrauterine device and factor V Leiden
por: Jean, Soluny
Publicado: (2019)

Acute mesenteric ischemia in an African American patient with heterozygous factor V Leiden deficiency
por: Barry, Hadiatou, et al.
Publicado: (2019)

Homozygous Factor V Leiden Thrombophilia in a Patient With Histologically Confirmed Thromboangiitis Obliterans
por: Mensa, Mussa, et al.
Publicado: (2019)

Arterial Thrombosis Associated with Factor V Leiden Mutation in a Child with Nephrotic Syndrome
por: Nagalla, Vamsi Krishna, et al.
Publicado: (2021)

Homozygous Factor V Leiden Complicated by Heparin-Induced Thrombocytopenia: A Case Report
por: Bautista Sanchez, Rocio, et al.
Publicado: (2022)

SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_du8qib5nl45unb4osqros2fv6n